- Home
- WORX vs DRMA Comparison
WORX vs DRMA Comparison
Compare WORX & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- DRMA
- Stock Information
- Founded
- WORX N/A
- DRMA 2014
- Country
- WORX United States
- DRMA United States
- Employees
- WORX N/A
- DRMA N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- DRMA Health Care
- Exchange
- WORX Nasdaq
- DRMA Nasdaq
- Market Cap
- WORX 1.8M
- DRMA 1.7M
- IPO Year
- WORX N/A
- DRMA 2021
- Fundamental
- Price
- WORX $0.88
- DRMA $1.07
- Analyst Decision
- WORX
- DRMA Strong Buy
- Analyst Count
- WORX 0
- DRMA 1
- Target Price
- WORX N/A
- DRMA $6.00
- AVG Volume (30 Days)
- WORX 29.7K
- DRMA 85.2K
- Earning Date
- WORX 11-26-2024
- DRMA 11-13-2024
- Dividend Yield
- WORX N/A
- DRMA N/A
- EPS Growth
- WORX N/A
- DRMA N/A
- EPS
- WORX N/A
- DRMA N/A
- Revenue
- WORX $3,224,146.00
- DRMA N/A
- Revenue This Year
- WORX N/A
- DRMA N/A
- Revenue Next Year
- WORX N/A
- DRMA N/A
- P/E Ratio
- WORX N/A
- DRMA N/A
- Revenue Growth
- WORX N/A
- DRMA N/A
- 52 Week Low
- WORX $0.75
- DRMA $1.11
- 52 Week High
- WORX $4.44
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- WORX 40.12
- DRMA 32.60
- Support Level
- WORX $1.09
- DRMA $1.22
- Resistance Level
- WORX $1.16
- DRMA $1.54
- Average True Range (ATR)
- WORX 0.07
- DRMA 0.11
- MACD
- WORX -0.01
- DRMA -0.02
- Stochastic Oscillator
- WORX 0.00
- DRMA 3.53
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.